Role of N-glycosylation on Zika virus E protein secretion, viral assembly and infectivity

Biochemical and Biophysical Research Communications

Volumn 492, Issue 4, 2017, Pages 579-586

  Mossenta, M ^a   Marchese, S ^a   Poggianella, M ^a   Slon Campos, J L ^a   Burrone, O R ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Envelope protein; Flavivirus; Glycosylation; Infectivity; Secretion; Zika virus

Indexed keywords

CAPSID PROTEIN; MEMBRANE PROTEIN; PROTEIN PRECURSOR; VIRAL PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; K-562 CELL LINE; MAMMAL CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REPLICON; TEMPERATURE DEPENDENCE; VERO CELL LINE; VIRUS ASSEMBLY; VIRUS INFECTIVITY; VIRUS PARTICLE; WEST NILE VIRUS; WILD TYPE; ZIKA VIRUS; ANIMAL; GLYCOSYLATION; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION; ZIKA FEVER;

ANIMALS; GLYCOSYLATION; HUMANS; K562 CELLS; PROTEIN DOMAINS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS ACTIVATION; VIRUS ASSEMBLY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85009812484     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.01.022     Document Type: Article

References (63)

1. Lazear, H.M., Diamond, M.S., Zika virus: New clinical syndromes and its emergence in the Western hemisphere. J. Virol. 90 (2016), 4864–4875.
2. Chang, C., Ortiz, K., Ansari, A., Gershwin, M.E., The Zika outbreak of the 21st century. J. Autoimmun. 68 (2016), 1–13.
3. Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika virus. N. Engl. J. Med. 374 (2016), 1552–1563.
4. Duffy, M.R., Chen, T.H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C., Guillaumot, L., Griggs, A., Bel, M., Lambert, A.J., Laven, J., Kosoy, O., Panella, A., Biggerstaff, B.J., Fischer, M., Hayes, E.B., Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360 (2009), 2536–2543.
5. Tognarelli, J., Ulloa, S., Villagra, E., Lagos, J., Aguayo, C., Fasce, R., Parra, B., Mora, J., Becerra, N., Lagos, N., Vera, L., Olivares, B., Vilches, M., Fernandez, J., A report on the outbreak of Zika virus on easter Island, south pacific, 2014. Arch. Virol. 161 (2016), 665–668.
6. Campos, G.S., Bandeira, A.C., Sardi, S.I., Zika virus outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21 (2015), 1885–1886.
7. Musso, D., Gubler, D.J., Zika virus. Clin. Microbiol. Rev. 29 (2016), 487–524.
8. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., Vial, A.L., Decam, C., Choumet, V., Halstead, S.K., Willison, H.J., Musset, L., Manuguerra, J.C., Despres, P., Fournier, E., Mallet, H.P., Musso, D., Fontanet, A., Neil, J., Ghawche, F., Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539.
9. Heukelbach, J., Alencar, C.H., Kelvin, A.A., de Oliveira, W.K., Pamplona de Goes Cavalcanti, L., Zika virus outbreak in Brazil. J. Infect. Dev. Ctries. 10 (2016), 116–120.
10. Mlakar, J., Korva, M., Tul, N., Popovic, M., Poljsak-Prijatelj, M., Mraz, J., Kolenc, M., Resman Rus, K., Vesnaver Vipotnik, T., Fabjan Vodusek, V., Vizjak, A., Pizem, J., Petrovec, M., Avsic Zupanc, T., Zika virus associated with microcephaly. N. Engl. J. Med. 374 (2016), 951–958.
11. Dowd, K.A., DeMaso, C.R., Pelc, R.S., Speer, S.D., Smith, A.R., Goo, L., Platt, D.J., Mascola, J.R., Graham, B.S., Mulligan, M.J., Diamond, M.S., Ledgerwood, J.E., Pierson, T.C., Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep. 16 (2016), 1485–1491.
12. Lindenbach, B.D., Rice, C.M., Molecular biology of flaviviruses. Adv. Virus Res. 59 (2003), 23–61.
13. Mukhopadhyay, S., Kuhn, R.J., Rossmann, M.G., A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3 (2005), 13–22.
14. Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., Jones, C.T., Mukhopadhyay, S., Chipman, P.R., Strauss, E.G., Baker, T.S., Strauss, J.H., Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002), 717–725.
15. Allison, S.L., Stadler, K., Mandl, C.W., Kunz, C., Heinz, F.X., Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69 (1995), 5816–5820.
16. Konishi, E., Mason, P.W., Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67 (1993), 1672–1675.
17. Lorenz, I.C., Kartenbeck, J., Mezzacasa, A., Allison, S.L., Heinz, F.X., Helenius, A., Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J. Virol. 77 (2003), 4370–4382.
18. Aebi, M., N-linked protein glycosylation in the ER. Biochim. Biophys. Acta 1833 (2013), 2430–2437.
19. Stanley, P., Golgi glycosylation. Cold Spring Harb. Perspect. Biol., 3, 2011.
20. Vigerust, D.J., Shepherd, V.L., Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15 (2007), 211–218.
21. Daniels, R., Kurowski, B., Johnson, A.E., Hebert, D.N., N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 11 (2003), 79–90.
22. Calarese, D.A., Lee, H.K., Huang, C.Y., Best, M.D., Astronomo, R.D., Stanfield, R.L., Katinger, H., Burton, D.R., Wong, C.H., Wilson, I.A., Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 13372–13377.
23. Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T.C., Rossmann, M.G., Kuhn, R.J., The 3.8 A resolution cryo-EM structure of Zika virus. Science 352 (2016), 467–470.
24. Hanna, S.L., Pierson, T.C., Sanchez, M.D., Ahmed, A.A., Murtadha, M.M., Doms, R.W., N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79 (2005), 13262–13274.
25. Bryant, J.E., Calvert, A.E., Mesesan, K., Crabtree, M.B., Volpe, K.E., Silengo, S., Kinney, R.M., Huang, C.Y., Miller, B.R., Roehrig, J.T., Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes. Virology 366 (2007), 415–423.
26. Beasley, D.W., Whiteman, M.C., Zhang, S., Huang, C.Y., Schneider, B.S., Smith, D.R., Gromowski, G.D., Higgs, S., Kinney, R.M., Barrett, A.D., Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 79 (2005), 8339–8347.
27. Haddow, A.D., Schuh, A.J., Yasuda, C.Y., Kasper, M.R., Heang, V., Huy, R., Guzman, H., Tesh, R.B., Weaver, S.C., Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis., 6, 2012, e1477.
28. Li, E., Pedraza, A., Bestagno, M., Mancardi, S., Sanchez, R., Burrone, O., Mammalian cell expression of dimeric small immune proteins (SIP). Protein Eng. 10 (1997), 731–736.
29. Hanke, T., Szawlowski, P., Randall, R.E., Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 73:Pt 3 (1992), 653–660.
30. Slon Campos, J.L., Poggianella, M., Marchese, S., Bestagno, M., Burrone, O.R., Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination. J. Gen. Virol. 96 (2015), 3265–3279.
31. Sambrook, J., Fritsch, E.F., Maniatis, T., Molecular Cloning: a Laboratory Manual. second ed., 1989, Cold Spring Harbor Laboratory Press, New York.
32. Poggianella, M., Slon Campos, J.L., Chan, K.R., Tan, H.C., Bestagno, M., Ooi, E.E., Burrone, O.R., Dengue E protein domain III-based DNA immunisation induces strong antibody responses to all four viral serotypes. PLoS Negl. Trop. Dis., 9, 2015, e0003947.
33. Henchal, E.A., Gentry, M.K., McCown, J.M., Brandt, W.E., Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31 (1982), 830–836.
34. Pierson, T.C., Sanchez, M.D., Puffer, B.A., Ahmed, A.A., Geiss, B.J., Valentine, L.E., Altamura, L.A., Diamond, M.S., Doms, R.W., A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346 (2006), 53–65.
35. Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J., Nelson, C.A., Pierson, T.C., Diamond, M.S., Fremont, D.H., Structural basis of Zika virus-specific antibody protection. Cell 166 (2016), 1016–1027.
36. Raman, R., Tharakaraman, K., Sasisekharan, V., Sasisekharan, R., Glycan-protein interactions in viral pathogenesis. Curr. Opin. Struct. Biol. 40 (2016), 153–162.
37. Moudy, R.M., Payne, A.F., Dodson, B.L., Kramer, L.D., Requirement of glycosylation of West Nile virus envelope protein for infection of, but not spread within, Culex quinquefasciatus mosquito vectors. Am. J. Trop. Med. Hyg. 85 (2011), 374–378.
38. Goto, A., Yoshii, K., Obara, M., Ueki, T., Mizutani, T., Kariwa, H., Takashima, I., Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. Vaccine 23 (2005), 3043–3052.
39. Adams, S.C., Broom, A.K., Sammels, L.M., Hartnett, A.C., Howard, M.J., Coelen, R.J., Mackenzie, J.S., Hall, R.A., Glycosylation and antigenic variation among Kunjin virus isolates. Virology 206 (1995), 49–56.
40. Post, P.R., Santos, C.N., Carvalho, R., Cruz, A.C., Rice, C.M., Galler, R., Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains. Virology 188 (1992), 160–167.
41. Mondotte, J.A., Lozach, P.Y., Amara, A., Gamarnik, A.V., Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J. Virol. 81 (2007), 7136–7148.
42. Whitby, K., Pierson, T.C., Geiss, B., Lane, K., Engle, M., Zhou, Y., Doms, R.W., Diamond, M.S., Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J. Virol. 79 (2005), 8698–8706.
43. Wu, S.F., Lee, C.J., Liao, C.L., Dwek, R.A., Zitzmann, N., Lin, Y.L., Antiviral effects of an iminosugar derivative on flavivirus infections. J. Virol. 76 (2002), 3596–3604.
44. Courageot, M.P., Frenkiel, M.P., Dos Santos, C.D., Deubel, V., Despres, P., Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J. Virol. 74 (2000), 564–572.
45. Rey, F.A., Heinz, F.X., Mandl, C., Kunz, C., Harrison, S.C., The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375 (1995), 291–298.
46. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 6986–6991.
47. Zheng, A., Umashankar, M., Kielian, M., In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS Pathog., 6, 2010, e1001157.
48. Tsai, W.Y., Hsieh, S.C., Lai, C.Y., Lin, H.E., Nerurkar, V.R., Wang, W.K., C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins. PLoS One, 7, 2012, e52600.
49. Hsieh, S.C., Tsai, W.Y., Nerurkar, V.R., Wang, W.K., Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein. PLoS One, 9, 2014, e100641.
50. Lee, E., Weir, R.C., Dalgarno, L., Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology 232 (1997), 281–290.
51. Moudy, R.M., Zhang, B., Shi, P.Y., Kramer, L.D., West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology 387 (2009), 222–228.
52. Li, J., Bhuvanakantham, R., Howe, J., Ng, M.L., The glycosylation site in the envelope protein of West Nile virus (Sarafend) plays an important role in replication and maturation processes. J. Gen. Virol. 87 (2006), 613–622.
53. Shirato, K., Miyoshi, H., Goto, A., Ako, Y., Ueki, T., Kariwa, H., Takashima, I., Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J. Gen. Virol. 85 (2004), 3637–3645.
54. Scherret, J.H., Mackenzie, J.S., Khromykh, A.A., Hall, R.A., Biological significance of glycosylation of the envelope protein of Kunjin virus. Ann. N. Y. Acad. Sci. 951 (2001), 361–363.
55. Murata, R., Eshita, Y., Maeda, A., Maeda, J., Akita, S., Tanaka, T., Yoshii, K., Kariwa, H., Umemura, T., Takashima, I., Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds. Am. J. Trop. Med. Hyg. 82 (2010), 696–704.
56. Vorndam, V., Mathews, J.H., Barrett, A.D., Roehrig, J.T., Trent, D.W., Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J. Gen. Virol. 74:Pt 12 (1993), 2653–2660.
57. Kariwa, H., Murata, R., Totani, M., Yoshii, K., Takashima, I., Increased pathogenicity of West Nile virus (WNV) by glycosylation of envelope protein and seroprevalence of WNV in wild birds in Far Eastern Russia. Int. J. Environ. Res. Public Health 10 (2013), 7144–7164.
58. Alen, M.M., Dallmeier, K., Balzarini, J., Neyts, J., Schols, D., Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection. Antivir. Res. 96 (2012), 280–287.
59. Kawano, H., Rostapshov, V., Rosen, L., Lai, C.J., Genetic determinants of dengue type 4 virus neurovirulence for mice. J. Virol. 67 (1993), 6567–6575.
60. Guirakhoo, F., Hunt, A.R., Lewis, J.G., Roehrig, J.T., Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 194 (1993), 219–223.
61. Johnson, A.J., Guirakhoo, F., Roehrig, J.T., The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203 (1994), 241–249.
62. McMinn, P.C., Weir, R.C., Dalgarno, L., A mouse-attenuated envelope protein variant of Murray Valley encephalitis virus with altered fusion activity. J. Gen. Virol. 77:Pt 9 (1996), 2085–2088.
63. Finkelstein, Y., Faktor, O., Elroy-Stein, O., Levi, B.Z., The use of bi-cistronic transfer vectors for the baculovirus expression system. J. Biotechnol. 75 (1999), 33–44.